Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001385508-18-000024
Filing Date
2018-03-07
Accepted
2018-03-07 16:17:19
Documents
91
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 10-KT opnt1231201710-k.htm 10-KT 1850502
2 EXHIBIT 23.1 consentopinion-opiant.htm EX-23.1 4716
3 EXHIBIT 31.1 opnt12312017exhibit311.htm EX-31.1 12062
4 EXHIBIT 31.2 opnt12312017exhibit312.htm EX-31.2 14788
5 EXHIBIT 32.1 opnt12312017exhibit321.htm EX-32.1 8369
6 EXHIBIT 32.2 opnt12312017exhibit322.htm EX-32.2 8384
  Complete submission text file 0001385508-18-000024.txt   8249506

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT opnt-20171031.xml EX-101.INS 1331911
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20171031.xsd EX-101.SCH 77929
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20171031_cal.xml EX-101.CAL 67365
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20171031_def.xml EX-101.DEF 411459
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20171031_lab.xml EX-101.LAB 855239
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20171031_pre.xml EX-101.PRE 583453
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 001-38193 | Film No.: 18673576
SIC: 1000 Metal Mining